PHARMACOLOGICAL TREATMENT OF PTSD WITH PSYCHEDELICS: A FUTURE OUTLOOK
International Journal of Innovative Technologies in Social Science December 24, 2025 Michal Gorski, Adam Januszkiewicz, Wiktoria Januszkiewicz et al.
About 3.9% of people worldwide experience Post Traumatic Stress Disorder (PTSD) in their lifetime, a condition marked by intrusive thoughts, hyperarousal, and avoidance after trauma. Standard treatments like psychotherapy and medication help only modestly for many, leaving chronic symptoms and related health problems. This narrative review synthesizes current knowledge on novel treatments, focusing on psychedelic drugs. It examines research on psychedelic therapy for PTSD, weighing benefits and drawbacks of different interventions, and asks what psychedelic-based pharmacological treatments exist or are emerging for PTSD patients and how they might be integrated into future clinical care. The review aims to offer practitioners and patients insights into the potential role of psychedelic compounds in PTSD treatment.